If vaccine manufacturers want smoother uptake of their vaccines in the US, they may want to consider how they study and price them.
Key Takeaways
-
Vaccine manufacturers may need more comprehensive clinical trial data and better price points to get the preferred universal age-based recommendations from the CDC.
Complaints about difficult-to-implement Centers for Disease Control and Prevention vaccine recommendations hindering uptake took center stage at a World Vaccines...





